Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1765 to 1773 of 1773 entries
Sorted by: Best Match Show Resources per page
Ophthalmological manifestations of the Schuurs-Hoeijmakers syndrome: a case report.

Arquivos brasileiros de oftalmologia

Barros E Silva MW, Martins A, Medeiros AL, Vasconcelos A, Ventura CV.
PMID: 34431888
Arq Bras Oftalmol. 2021 Aug 18; doi: 10.5935/0004-2749.20220013. Epub 2021 Aug 18.

This is a case report of a 2-year-old male patient with cognitive delay, facial abnormalities, and microcornea in the right eye, who was referred for ophthalmological investigation. The initial ophthalmological examination revealed hypertelorism, epicanthus, nystagmus, esotropia, and microcornea in...

Cite
Barros E Silva MW, Martins A, Medeiros AL, et al. Ophthalmological manifestations of the Schuurs-Hoeijmakers syndrome: a case report. Arq Bras Oftalmol. 2021;doi: 10.5935/0004-2749.20220013.
Barros E Silva, M. W., Martins, A., Medeiros, A. L., Vasconcelos, A., & Ventura, C. V. (2021). Ophthalmological manifestations of the Schuurs-Hoeijmakers syndrome: a case report. Arquivos brasileiros de oftalmologia, . https://doi.org/10.5935/0004-2749.20220013
Barros E Silva, Mariana W de, et al. "Ophthalmological manifestations of the Schuurs-Hoeijmakers syndrome: a case report." Arquivos brasileiros de oftalmologia vol. (2021). doi: https://doi.org/10.5935/0004-2749.20220013
Barros E Silva MW, Martins A, Medeiros AL, Vasconcelos A, Ventura CV. Ophthalmological manifestations of the Schuurs-Hoeijmakers syndrome: a case report. Arq Bras Oftalmol. 2021 Aug 18; doi: 10.5935/0004-2749.20220013. Epub 2021 Aug 18. PMID: 34431888.
Copy Download .nbib Format: NLM
Mortality and Major Neonatal Morbidity in Preterm Infants with Serious Congenital Heart Disease.

The Journal of pediatrics

Steurer MA, Baer RJ, Chambers CD, Costello J, Franck LS, McKenzie-Sampson S, Pacheco-Werner TL, Rajagopal S, Rogers EE, Rand L, Jelliffe-Pawlowski LL, Peyvandi S.
PMID: 34454949
J Pediatr. 2021 Dec;239:110-116.e3. doi: 10.1016/j.jpeds.2021.08.039. Epub 2021 Aug 26.

OBJECTIVE: To investigate the trends of 1-year mortality and neonatal morbidities in preterm infants with serious congenital heart disease (CHD).STUDY DESIGN: This cohort study used a population-based administrative dataset of all liveborn infants of 26-36 weeks gestational age with...

Cite
Steurer MA, Baer RJ, Chambers CD, et al. Mortality and Major Neonatal Morbidity in Preterm Infants with Serious Congenital Heart Disease. J Pediatr. 2021;239:110-116.e3doi: 10.1016/j.jpeds.2021.08.039.
Steurer, M. A., Baer, R. J., Chambers, C. D., Costello, J., Franck, L. S., McKenzie-Sampson, S., Pacheco-Werner, T. L., Rajagopal, S., Rogers, E. E., Rand, L., Jelliffe-Pawlowski, L. L., & Peyvandi, S. (2021). Mortality and Major Neonatal Morbidity in Preterm Infants with Serious Congenital Heart Disease. The Journal of pediatrics, 239110-116.e3. https://doi.org/10.1016/j.jpeds.2021.08.039
Steurer, Martina A, et al. "Mortality and Major Neonatal Morbidity in Preterm Infants with Serious Congenital Heart Disease." The Journal of pediatrics vol. 239 (2021): 110-116.e3. doi: https://doi.org/10.1016/j.jpeds.2021.08.039
Steurer MA, Baer RJ, Chambers CD, Costello J, Franck LS, McKenzie-Sampson S, Pacheco-Werner TL, Rajagopal S, Rogers EE, Rand L, Jelliffe-Pawlowski LL, Peyvandi S. Mortality and Major Neonatal Morbidity in Preterm Infants with Serious Congenital Heart Disease. J Pediatr. 2021 Dec;239:110-116.e3. doi: 10.1016/j.jpeds.2021.08.039. Epub 2021 Aug 26. PMID: 34454949.
Copy Download .nbib Format: NLM
TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy.

Dermatology (Basel, Switzerland)

Martins F, Martins C, Fernandes MS, Andrade MI, Lopes JM, Soares P, Pópulo H.
PMID: 34569488
Dermatology. 2021 Sep 21;1-10. doi: 10.1159/000518219. Epub 2021 Sep 21.

BACKGROUND: While BRAF mutations seem important for early melanomagenesis, mutations in the TERT promoter (TERTp) are related to metastasis. Yet, in conventional melanoma management, risk stratification does not depend on molecular biomarkers that can indicate the stage of progression,...

Cite
Martins F, Martins C, Fernandes MS, et al. TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy. Dermatology. 2021;1-10doi: 10.1159/000518219.
Martins, F., Martins, C., Fernandes, M. S., Andrade, M. I., Lopes, J. M., Soares, P., & Pópulo, H. (2021). TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy. Dermatology (Basel, Switzerland), 1-10. https://doi.org/10.1159/000518219
Martins, Francisco, et al. "TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy." Dermatology (Basel, Switzerland) vol. (2021): 1-10. doi: https://doi.org/10.1159/000518219
Martins F, Martins C, Fernandes MS, Andrade MI, Lopes JM, Soares P, Pópulo H. TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy. Dermatology. 2021 Sep 21;1-10. doi: 10.1159/000518219. Epub 2021 Sep 21. PMID: 34569488.
Copy Download .nbib Format: NLM
Towards a European strategy to address the COVID-19 pandemic.

Lancet (London, England)

Priesemann V, Balling R, Bauer S, Beutels P, Valdez AC, Cuschieri S, Czypionka T, Dumpis U, Glaab E, Grill E, Hotulainen P, Iftekhar EN, Krutzinna J, Lionis C, Machado H, Martins C, McKee M, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Prainsack B, Rocklöv J, Schernhammer E, Szczurek E, Tsiodras S, Van Gucht S, Willeit P.
PMID: 34384539
Lancet. 2021 Sep 04;398(10303):838-839. doi: 10.1016/S0140-6736(21)01808-0. Epub 2021 Aug 09.

No abstract available.

Cite
Priesemann V, Balling R, Bauer S, et al. Towards a European strategy to address the COVID-19 pandemic. Lancet. 2021;398(10303):838-839doi: 10.1016/S0140-6736(21)01808-0.
Priesemann, V., Balling, R., Bauer, S., Beutels, P., Valdez, A. C., Cuschieri, S., Czypionka, T., Dumpis, U., Glaab, E., Grill, E., Hotulainen, P., Iftekhar, E. N., Krutzinna, J., Lionis, C., Machado, H., Martins, C., McKee, M., Pavlakis, G. N., Perc, M., Petelos, E., Pickersgill, M., Prainsack, B., Rocklöv, J., Schernhammer, E., Szczurek, E., Tsiodras, S., Van Gucht, S., & Willeit, P. (2021). Towards a European strategy to address the COVID-19 pandemic. Lancet (London, England), 398(10303), 838-839. https://doi.org/10.1016/S0140-6736(21)01808-0
Priesemann, Viola, et al. "Towards a European strategy to address the COVID-19 pandemic." Lancet (London, England) vol. 398,10303 (2021): 838-839. doi: https://doi.org/10.1016/S0140-6736(21)01808-0
Priesemann V, Balling R, Bauer S, Beutels P, Valdez AC, Cuschieri S, Czypionka T, Dumpis U, Glaab E, Grill E, Hotulainen P, Iftekhar EN, Krutzinna J, Lionis C, Machado H, Martins C, McKee M, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Prainsack B, Rocklöv J, Schernhammer E, Szczurek E, Tsiodras S, Van Gucht S, Willeit P. Towards a European strategy to address the COVID-19 pandemic. Lancet. 2021 Sep 04;398(10303):838-839. doi: 10.1016/S0140-6736(21)01808-0. Epub 2021 Aug 09. PMID: 34384539; PMCID: PMC8352491.
Copy Download .nbib Format: NLM
Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients.

Genetics and molecular biology

Müller KB, Galdieri LC, Pereira VG, Martins AM, D'Almeida V.
PMID: 22888289
Genet Mol Biol. 2012 Apr;35(2):418-23. doi: 10.1590/S1415-47572012005000031. Epub 2012 May 17.

Fabry Disease, an X-linked inborn error of metabolism, is characterized by progressive renal insufficiency, with cardio and cerebrovascular involvement. Homocysteine (Hcy) is considered a risk factor for vascular diseases, but the mechanisms by which it produces cardiovascular damage are...

Cite
Müller KB, Galdieri LC, Pereira VG, et al. Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients. Genet Mol Biol. 2012;35(2):418-23doi: 10.1590/S1415-47572012005000031.
Müller, K. B., Galdieri, L. C., Pereira, V. G., Martins, A. M., & D'Almeida, V. (2012). Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients. Genetics and molecular biology, 35(2), 418-23. https://doi.org/10.1590/S1415-47572012005000031
Müller, Karen B, et al. "Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients." Genetics and molecular biology vol. 35,2 (2012): 418-23. doi: https://doi.org/10.1590/S1415-47572012005000031
Müller KB, Galdieri LC, Pereira VG, Martins AM, D'Almeida V. Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients. Genet Mol Biol. 2012 Apr;35(2):418-23. doi: 10.1590/S1415-47572012005000031. Epub 2012 May 17. PMID: 22888289; PMCID: PMC3389528.
Copy Download .nbib Format: NLM
Field-Based Health-Related Physical Fitness Tests in Children and Adolescents: A Systematic Review.

Frontiers in pediatrics

Marques A, Henriques-Neto D, Peralta M, Martins J, Gomes F, Popovic S, Masanovic B, Demetriou Y, Schlund A, Ihle A.
PMID: 33748047
Front Pediatr. 2021 Mar 05;9:640028. doi: 10.3389/fped.2021.640028. eCollection 2021.

Physical fitness (PF) is a multi-component construct and a biomarker of health. Worse PF is related to vulnerability and predicts worse academic achievements. Thus, assessing PF is important to monitor health in youth. This systematic review aimed to identify...

Cite
Marques A, Henriques-Neto D, Peralta M, et al. Field-Based Health-Related Physical Fitness Tests in Children and Adolescents: A Systematic Review. Front Pediatr. 2021;9:640028doi: 10.3389/fped.2021.640028.
Marques, A., Henriques-Neto, D., Peralta, M., Martins, J., Gomes, F., Popovic, S., Masanovic, B., Demetriou, Y., Schlund, A., & Ihle, A. (2021). Field-Based Health-Related Physical Fitness Tests in Children and Adolescents: A Systematic Review. Frontiers in pediatrics, 9640028. https://doi.org/10.3389/fped.2021.640028
Marques, Adilson, et al. "Field-Based Health-Related Physical Fitness Tests in Children and Adolescents: A Systematic Review." Frontiers in pediatrics vol. 9 (2021): 640028. doi: https://doi.org/10.3389/fped.2021.640028
Marques A, Henriques-Neto D, Peralta M, Martins J, Gomes F, Popovic S, Masanovic B, Demetriou Y, Schlund A, Ihle A. Field-Based Health-Related Physical Fitness Tests in Children and Adolescents: A Systematic Review. Front Pediatr. 2021 Mar 05;9:640028. doi: 10.3389/fped.2021.640028. eCollection 2021. PMID: 33748047; PMCID: PMC7973114.
Copy Download .nbib Format: NLM
Integrated bioprocess for structured lipids, emulsifiers and biodiesel production using crude acidic olive pomace oils.

Bioresource technology

Heinzl GC, Mota DA, Martinis V, Martins AS, Soares CMF, Osório N, Gominho J, Madhavan Nampoothiri K, Sukumaran RK, Pereira H, Ferreira-Dias S.
PMID: 34974092
Bioresour Technol. 2021 Dec 30;346:126646. doi: 10.1016/j.biortech.2021.126646. Epub 2021 Dec 30.

Olive pomace oil (OPO), a by-product of olive oil industry, is directly consumed after refining. The novelty of this study consists of the direct use of crude high acidic OPO (3.4-20% acidity) to produce added-value compounds, using sn-1,3-regioselective lipases:...

Cite
Heinzl GC, Mota DA, Martinis V, et al. Integrated bioprocess for structured lipids, emulsifiers and biodiesel production using crude acidic olive pomace oils. Bioresour Technol. 2021;346:126646doi: 10.1016/j.biortech.2021.126646.
Heinzl, G. C., Mota, D. A., Martinis, V., Martins, A. S., Soares, C. M. F., Osório, N., Gominho, J., Madhavan Nampoothiri, K., Sukumaran, R. K., Pereira, H., & Ferreira-Dias, S. (2021). Integrated bioprocess for structured lipids, emulsifiers and biodiesel production using crude acidic olive pomace oils. Bioresource technology, 346126646. https://doi.org/10.1016/j.biortech.2021.126646
Heinzl, Giuditta C, et al. "Integrated bioprocess for structured lipids, emulsifiers and biodiesel production using crude acidic olive pomace oils." Bioresource technology vol. 346 (2021): 126646. doi: https://doi.org/10.1016/j.biortech.2021.126646
Heinzl GC, Mota DA, Martinis V, Martins AS, Soares CMF, Osório N, Gominho J, Madhavan Nampoothiri K, Sukumaran RK, Pereira H, Ferreira-Dias S. Integrated bioprocess for structured lipids, emulsifiers and biodiesel production using crude acidic olive pomace oils. Bioresour Technol. 2021 Dec 30;346:126646. doi: 10.1016/j.biortech.2021.126646. Epub 2021 Dec 30. PMID: 34974092.
Copy Download .nbib Format: NLM
Biomimetic 3D Environment Based on Microgels as a Model for the Generation of Drug Resistance in Multiple Myeloma.

Materials (Basel, Switzerland)

Marín-Payá JC, Díaz-Benito B, Martins LA, Trujillo SC, Cordón L, Lanceros-Méndez S, Gallego Ferrer G, Sempere A, Gómez Ribelles JL.
PMID: 34885273
Materials (Basel). 2021 Nov 23;14(23). doi: 10.3390/ma14237121.

The development of three-dimensional environments to mimic the in vivo cellular response is a problem in the building of disease models. This study aimed to synthesize and validate three-dimensional support for culturing monoclonal plasma cells (mPCs) as a disease...

Cite
Marín-Payá JC, Díaz-Benito B, Martins LA, et al. Biomimetic 3D Environment Based on Microgels as a Model for the Generation of Drug Resistance in Multiple Myeloma. Materials (Basel). 2021;14(23)doi: 10.3390/ma14237121.
Marín-Payá, J. C., Díaz-Benito, B., Martins, L. A., Trujillo, S. C., Cordón, L., Lanceros-Méndez, S., Gallego Ferrer, G., Sempere, A., & Gómez Ribelles, J. L. (2021). Biomimetic 3D Environment Based on Microgels as a Model for the Generation of Drug Resistance in Multiple Myeloma. Materials (Basel, Switzerland), 14(23), . https://doi.org/10.3390/ma14237121
Marín-Payá, Juan Carlos, et al. "Biomimetic 3D Environment Based on Microgels as a Model for the Generation of Drug Resistance in Multiple Myeloma." Materials (Basel, Switzerland) vol. 14,23 (2021). doi: https://doi.org/10.3390/ma14237121
Marín-Payá JC, Díaz-Benito B, Martins LA, Trujillo SC, Cordón L, Lanceros-Méndez S, Gallego Ferrer G, Sempere A, Gómez Ribelles JL. Biomimetic 3D Environment Based on Microgels as a Model for the Generation of Drug Resistance in Multiple Myeloma. Materials (Basel). 2021 Nov 23;14(23). doi: 10.3390/ma14237121. PMID: 34885273; PMCID: PMC8658353.
Copy Download .nbib Format: NLM
Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model.

Cells

Martens A, de Buhr N, Ishikawa H, Schroten H, von Köckritz-Blickwede M.
PMID: 35011713
Cells. 2022 Jan 04;11(1). doi: 10.3390/cells11010151.

The host-pathogen interaction during meningitis can be investigated with blood-cerebrospinal-fluid-barrier (BCSFB) cell culture models. They are commonly handled under atmospheric oxygen conditions (19-21% O

Cite
Martens A, de Buhr N, Ishikawa H, et al. Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model. Cells. 2022;11(1)doi: 10.3390/cells11010151.
Martens, A., de Buhr, N., Ishikawa, H., Schroten, H., & von Köckritz-Blickwede, M. (2022). Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model. Cells, 11(1), . https://doi.org/10.3390/cells11010151
Martens, Alexander, et al. "Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model." Cells vol. 11,1 (2022). doi: https://doi.org/10.3390/cells11010151
Martens A, de Buhr N, Ishikawa H, Schroten H, von Köckritz-Blickwede M. Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model. Cells. 2022 Jan 04;11(1). doi: 10.3390/cells11010151. PMID: 35011713; PMCID: PMC8750020.
Copy Download .nbib Format: NLM
Showing 1765 to 1773 of 1773 entries